Interlaboratory study to validate a STR profiling method for intraspecies identification of mouse cell lines.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 08 03 2019
accepted: 31 05 2019
entrez: 21 6 2019
pubmed: 21 6 2019
medline: 14 2 2020
Statut: epublish

Résumé

The Consortium for Mouse Cell Line Authentication was formed to validate Short Tandem Repeat (STR) markers for intraspecies identification of mouse cell lines. The STR profiling method is a multiplex polymerase chain reaction (PCR) assay comprised of primers targeting 19 mouse STR markers and two human STR markers (for interspecies contamination screening). The goals of the Consortium were to perform an interlaboratory study to-(1) validate the mouse STR markers to uniquely identify mouse cell lines (intraspecies identification), (2) to provide a public database of mouse cell lines with the National Institute of Standards and Technology (NIST)-validated mouse STR profiles, and (3) to publish the results of the interlaboratory study. The interlaboratory study was an international effort that consisted of 12 participating laboratories representing institutions from academia, industry, biological resource centers, and government. The study was based on 50 of the most commonly used mouse cell lines obtained from the American Type Culture Collection (ATCC). Of the 50 mouse cell lines, 18 had unique STR profiles that were 100% concordant (match) among all Consortium laboratory members, and the remaining 32 cell lines had discordance that was resolved readily and led to improvement of the assay. The discordance was due to low signal and interpretation issues involving artifacts and genotyping errors. Although the total number of discordant STR profiles was relatively high in this study, the percent of labs agreeing on allele calls among the discordant samples was above 92%. The STR profiles, including electropherogram images, for NIST-validated mouse cell lines will be published on the NCBI BioSample Database (https://www.ncbi.nlm.nih.gov/biosample/). Overall, the interlaboratory study showed that the multiplex PCR method using 18 of the 19 mouse STR markers is capable of discriminating at the intraspecies level between mouse cell lines. Further studies are ongoing to refine the assay including (1) development of an allelic ladder for improving the accuracy of allele calling and (2) integration of stutter filters to identify true stutter.

Identifiants

pubmed: 31220119
doi: 10.1371/journal.pone.0218412
pii: PONE-D-19-07032
pmc: PMC6586308
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0218412

Déclaration de conflit d'intérêts

I have read the journal's policy and the authors of this manuscript have the following competing interests: NIST was awarded a patent by the United States Patent Office (9,556,482 B2) for mouse cell line authentication. For full disclosure, this technology is licensed to IDEXX BioAnalytics and ATCC for commercialization; both companies have authorship on this manuscript. NIST and the inventors have received payments and will potentially receive royalties. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Références

In Vitro Cell Dev Biol Anim. 2007 Nov-Dec;43(10):344-51
pubmed: 17934781
Cell Biol Toxicol. 2007 Nov;23(6):367-72
pubmed: 17522957
BMC Biotechnol. 2011 Nov 07;11:102
pubmed: 22059503
J Forensic Sci. 2001 May;46(3):647-60
pubmed: 11373004
Cytotechnology. 2014 Jan;66(1):133-47
pubmed: 23430347
Clin Diagn Virol. 1994 Apr;2(2):95-103
pubmed: 15566757
Biotechniques. 2015 Oct 01;59(4):189-90, 192
pubmed: 26458546
Hum Mol Genet. 1993 Apr;2(4):411-5
pubmed: 8504301
PLoS One. 2017 Oct 12;12(10):e0186281
pubmed: 29023500
Science. 1981 Apr 24;212(4493):446-52
pubmed: 6451928
PLoS Biol. 2016 Jun 14;14(6):e1002477
pubmed: 27300550
Front Oncol. 2018 Jul 20;8:268
pubmed: 30079312
J Forensic Sci. 2009 Sep;54(5):1008-15
pubmed: 19627417
Int J Cancer. 2013 Jun 1;132(11):2510-9
pubmed: 23136038
Nucleic Acids Res. 1996 Jul 15;24(14):2807-12
pubmed: 8759015
Nat Methods. 2015 Jun;12(6):493-7
pubmed: 26020501
Forensic Sci Int. 2001 Jun 1;119(1):1-10
pubmed: 11348787
J Exp Med. 1979 Dec 1;150(6):1510-9
pubmed: 92524
Biotechniques. 1996 Jun;20(6):1004-6, 1008-10
pubmed: 8780871
Int J Cancer. 2010 Jul 1;127(1):1-8
pubmed: 20143388

Auteurs

Jamie L Almeida (JL)

National Institute of Standards and Technology, Biosystems and Biomaterials Division, Gaithersburg, Maryland, United States of America.

Aleksandra Dakic (A)

ATCC, Standards Resource Center, Manassas, Virginia, United States of America.

Karin Kindig (K)

ATCC, Standards Resource Center, Manassas, Virginia, United States of America.

Maikan Kone (M)

ATCC, Standards Resource Center, Manassas, Virginia, United States of America.

Deborah L D Letham (DLD)

Charles River Laboratories, Malvern, Pennsylvania, United States of America.

Scott Langdon (S)

Duke University, Durham, North Carolina, United States of America.

Ruth Peat (R)

The Francis Crick Institute, Cell Services, London, United Kingdom.

Jayamalini Holding-Pillai (J)

The Francis Crick Institute, Cell Services, London, United Kingdom.

Erin M Hall (EM)

Genetica Cell Line Testing -a LabCorp brand, Burlington, North Carolina, United States of America.

Mark Ladd (M)

Genetica Cell Line Testing -a LabCorp brand, Burlington, North Carolina, United States of America.

Megan D Shaffer (MD)

Genetica Cell Line Testing -a LabCorp brand, Burlington, North Carolina, United States of America.

Heath Berg (H)

IDEXX BioAnalytics, Columbia, Missouri, United States of America.

Jinliang Li (J)

Laragen Inc., Culver City, California, United States of America.

Georges Wigger (G)

Microsynth AG, Balgach, Switzerland.

Steve Lund (S)

National Institute of Standards and Technology, Statistical Engineering Division, Gaithersburg, Maryland, United States of America.

Carolyn R Steffen (CR)

National Institute of Standards and Technology, Biomolecular Measurement Division, Gaithersburg, Maryland, United States of America.

Barbara B Fransway (BB)

University of Arizona, Genetics Core Lab, University of Arizona Genetics Core, Tucson, Arizona, United States of America.

Bob Geraghty (B)

University of Cambridge, Cancer Research UK, Cambridge Institute, Cambridge, United Kingdom.

Manuela Natoli (M)

University of Cambridge, Cancer Research UK, Cambridge Institute, Cambridge, United Kingdom.

Beth Bauer (B)

University of Maryland, College Park, Maryland.

Susanne M Gollin (SM)

University of Pittsburgh, Department of Human Genetics, Pittsburgh, Pennsylvania, United States of America.

Dale W Lewis (DW)

University of Pittsburgh, Department of Human Genetics, Pittsburgh, Pennsylvania, United States of America.

Yvonne Reid (Y)

National Institute of Standards and Technology, Biosystems and Biomaterials Division, Gaithersburg, Maryland, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH